Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular histones are nuclear proteins that, when released outside the cell, act as potent damage-associated molecular patterns (DAMPs) involved in inflammation and tissue injury. They are released during cell death, NETosis, or cellular stress and can exist as free proteins, DNA-bound nucleosomes, or components of NETs. They activate immune cells via TLR2/4/9 and P2XR7 receptors, leading to pro-inflammatory cytokine release, endothelial dysfunction, and thrombosis. Elevated levels are implicated in various critical illnesses, making them a therapeutic target for intervention.
Blocking release from dying cells or NETs formation; Neutralizing circulating histones; Inhibiting downstream signaling pathways (e.g., TLR)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Histone (None).